ELIX.F Stock Overview
Operates as a cannabis investment firm in Canada, Australia, Italy, Jamaica, and Switzerland. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Elixxer Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.0061 |
| 52 Week High | US$0.017 |
| 52 Week Low | US$0.0061 |
| Beta | 3.96 |
| 11 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 33 Year Change | -99.27% |
| 5 Year Change | -99.89% |
| Change since IPO | -99.98% |
Recent News & Updates
Recent updates
Shareholder Returns
| ELIX.F | US Capital Markets | US Market | |
|---|---|---|---|
| 7D | 0% | 3.0% | 2.2% |
| 1Y | n/a | 57.6% | 31.6% |
Return vs Industry: Insufficient data to determine how ELIX.F performed against the US Capital Markets industry.
Return vs Market: Insufficient data to determine how ELIX.F performed against the US Market.
Price Volatility
| ELIX.F volatility | |
|---|---|
| ELIX.F Average Weekly Movement | n/a |
| Capital Markets Industry Average Movement | 3.9% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in US Market | 15.7% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: ELIX.F has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine ELIX.F's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2004 | n/a | Ferras Zalt | www.elixxer.com |
Elixxer Ltd. operates as a cannabis investment firm in Canada, Australia, Italy, Jamaica, and Switzerland. It invests in cultivation, production, and/or sale of medical cannabis and cannabis-derived products in the pharmaceutical sector. The company was formerly known as LGC Capital Ltd.
Elixxer Ltd. Fundamentals Summary
| ELIX.F fundamental statistics | |
|---|---|
| Market cap | US$69.17k |
| Earnings (TTM) | -US$4.58m |
| Revenue (TTM) | n/a |
0.0x
P/S Ratio0.0x
P/E RatioIs ELIX.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ELIX.F income statement (TTM) | |
|---|---|
| Revenue | CA$0 |
| Cost of Revenue | CA$0 |
| Gross Profit | CA$0 |
| Other Expenses | CA$6.17m |
| Earnings | -CA$6.17m |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.54 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | -104.8% |
How did ELIX.F perform over the long term?
See historical performance and comparison